Description

Spiro[Benzimidazoline-2,1-[2]Cyclohexene], 4,4-Dimethyl- (8Ci) is a specialized spirocyclic organic compound featuring a fused benzimidazoline and cyclohexene ring system. This unique molecular architecture makes it a valuable advanced intermediate and building block for the synthesis of complex molecules in pharmaceutical and agrochemical research. It is primarily sought by R&D chemists and process development scientists working on novel active ingredients, heterocyclic ligands, and functional materials.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders or requiring complex heterocyclic scaffolds.
• Agrochemical Research: Used as a building block for developing new pesticides, herbicides, or fungicides with potential novel modes of action.
• Ligand Synthesis: The spirocyclic structure can be functionalized to create unique ligands for catalysis or metal-organic frameworks (MOFs).
• Material Science: Potential intermediate for the development of organic electronic materials or specialty polymers.
• Academic & Industrial R&D: A valuable tool compound for methodological studies in organic synthesis and medicinal chemistry.

Basic Information

Product Name	Spiro[Benzimidazoline-2,1-[2]Cyclohexene], 4,4-Dimethyl- (8Ci)
CAS No.	801199-84-8
Molecular Formula	C14H16N2
Molecular Weight	212.29 g/mol
Synonyms	4,4-Dimethylspiro[benzimidazoline-2,1'-cyclohexene]; 4,4-Dimethyl-1'H-spiro[cyclohexene-1,2'-benzimidazoline]; Spiro[cyclohexene-1,2'-benzimidazoline], 4,4-dimethyl-; 4,4-Dimethylspiro[cyclohexene-1,2'-benzimidazoline]; 1'H-Spiro[cyclohexene-1,2'-benzimidazoline], 4,4-dimethyl-
EINECS	Contact for details

Quality Control

Our Spiro[Benzimidazoline-2,1-[2]Cyclohexene], 4,4-Dimethyl- (8Ci) is produced under strict quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure high purity and structural identity. A detailed Certificate of Analysis (COA) is provided with each shipment, confirming compliance with agreed specifications. We support cGMP standards for advanced intermediates intended for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder or crystalline solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0% (Standard Grade)
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.